CN103127433B - 一种治疗肺癌的中药及其制备方法 - Google Patents
一种治疗肺癌的中药及其制备方法 Download PDFInfo
- Publication number
- CN103127433B CN103127433B CN201310073474.4A CN201310073474A CN103127433B CN 103127433 B CN103127433 B CN 103127433B CN 201310073474 A CN201310073474 A CN 201310073474A CN 103127433 B CN103127433 B CN 103127433B
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- treatment
- medical material
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 206010058467 Lung neoplasm malignant Diseases 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 201000005202 lung cancer Diseases 0.000 title abstract description 11
- 208000020816 lung neoplasm Diseases 0.000 title abstract description 11
- 241000489492 Arisaema Species 0.000 claims abstract description 20
- 210000000941 bile Anatomy 0.000 claims abstract description 20
- 210000000582 semen Anatomy 0.000 claims description 40
- 239000012567 medical material Substances 0.000 claims description 27
- 239000009636 Huang Qi Substances 0.000 claims description 21
- 241001250596 Pleione Species 0.000 claims description 19
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 19
- 239000002775 capsule Substances 0.000 claims description 10
- 239000006187 pill Substances 0.000 claims description 10
- 239000002671 adjuvant Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 238000007796 conventional method Methods 0.000 claims description 4
- 238000002481 ethanol extraction Methods 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 28
- 230000007812 deficiency Effects 0.000 abstract description 18
- 238000001959 radiotherapy Methods 0.000 abstract description 9
- 238000002512 chemotherapy Methods 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract 2
- 241001412627 Adenophora liliifolia Species 0.000 abstract 1
- 244000144725 Amygdalus communis Species 0.000 abstract 1
- 235000011437 Amygdalus communis Nutrition 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 241000157511 Oldenlandia Species 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241001671204 Stemona Species 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 235000020224 almond Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 239000008262 pumice Substances 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 38
- 239000008280 blood Substances 0.000 description 36
- 210000004369 blood Anatomy 0.000 description 35
- 206010011224 Cough Diseases 0.000 description 27
- 206010062717 Increased upper airway secretion Diseases 0.000 description 27
- 208000026435 phlegm Diseases 0.000 description 27
- 235000009508 confectionery Nutrition 0.000 description 18
- 230000006870 function Effects 0.000 description 17
- 239000000796 flavoring agent Substances 0.000 description 15
- 235000019634 flavors Nutrition 0.000 description 15
- 210000000952 spleen Anatomy 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- 230000003203 everyday effect Effects 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 206010047700 Vomiting Diseases 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 210000000038 chest Anatomy 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 208000006673 asthma Diseases 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 239000003172 expectorant agent Substances 0.000 description 7
- 230000003419 expectorant effect Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- 208000013116 chronic cough Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 5
- 206010036790 Productive cough Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 208000033809 Suppuration Diseases 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 201000007227 lymph node tuberculosis Diseases 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 201000003453 lung abscess Diseases 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000007123 Pulmonary Atelectasis Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 240000006394 Sorghum bicolor Species 0.000 description 2
- 235000007230 Sorghum bicolor Nutrition 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000517306 Pediculus humanus corporis Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000013276 bronchoscopy Methods 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 239000010243 sho-seiryu-to Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗肺癌的中药及其制备方法。该治疗肺癌的中药,由以下重量份数的药材制成:西洋参1-50份、黄芪1-50份、浮海石1-50份、百部1-50份、栝楼1-50份、杏仁1-50份、胆星1-15份、薏苡仁1-50份、五味子1-50份、百合1-50份、茯苓1-50份、白术1-50份、甘草1-50份、麦门冬1-50份、浙贝母1-50份、半夏1-50份、沙参1-50份、白花蛇舌草1-50份、当归1-50份、桔梗1-50份。诸药合用,对各种肺癌有显著的疗效,尤其对气阴两虚型的肺癌有着更为显著的疗效。同时本药物发明配合手术、放疗、化疗,可以起到减少放疗化疗的毒副作用,可以显著提高放疗化疗的疗效。
Description
(一) 技术领域
本发明属于中药技术领域,具体涉及一种治疗肺癌的中药及其制备方法。
(二) 背景技术
肺癌是常见的恶性肿瘤之一,发病率高居全部肿瘤的第一、二位,随着环境污染的加剧,肺癌的发病率越来越高,而且年龄越来越年轻,严重的威胁着人们的身体健康。早期肺癌一般采用手术治疗是获得治愈及远程治疗的可靠手段,但能够根治者不足30%。传统的放疗和化疗对部分肺癌患者近期有效,但是毒副作用大,而且复发转移率较高,多数仅有姑息效果。肺癌的总体疗效较差,越80%的患者在1年内死亡,5年的生产率不足10%。
肺癌属于中医学“肺积”,“痞癖”,“咳嗽”,“咯血”,“肺痛”灯范畴。肺癌的发生是由于人体的正气虚损,阴阳失调,邪毒乘虚入肺,邪滞于肺,导致肺功能失调,肺气膹郁,宣降失司,气机不利,血行受阻,津液失于输布,津聚为痰,谈凝气滞,痰阻络脉,于是瘀毒胶结,日久形成肺部积块。
(三) 发明内容
本发明为了弥补现有技术的不足,提供了一种疗效好、治愈率高的治疗肺癌的中药及其制备方法。
本发明是通过如下技术方案实现的:
一种治疗肺癌的中药,其特殊之处在于:由以下重量份数的药材制成:
西洋参1-50份、黄芪1-50份、浮海石1-50份、生地1-50份、熟地1-50份、百部1-50份、栝楼1-50份、杏仁1-50份、玄参1-50份、山慈菇1-50份、胆星1-15份、薏苡仁1-50份、五味子1-50份、百合1-50份、茯苓1-50份、白术1-50份、甘草1-50份、麦门冬1-50份、浙贝母1-50份、半夏1-50份、沙参1-50份、白花蛇舌草1-50份、当归1-50份、桔梗1-50份。
本发明的治疗肺癌的中药,优选方案为:由以下重量份数的药材制成:
西洋参1-50份、黄芪1-50份、浮海石1-20份、生地1-20份、熟地1-20份、百部1-15份、栝楼1-20份、杏仁1-15份、玄参1-20份、山慈菇1-20份、胆星1-15份、薏苡仁1-50份、五味子1-20份、百合1-20份、茯苓1-30份、白术1-30份、甘草1-30份、麦门冬1-20份、浙贝母1-20份、半夏1-20份、沙参1-30份、白花蛇舌草1-20份、当归1-20份、桔梗1-20份。
本发明的治疗肺癌中药的制备方法,将其药材和/或其有效成分和/或药学上可接受的辅料一起制成散剂或袋泡剂、口服液、胶囊剂、片剂、丸剂或颗粒剂。
本发明的治疗肺癌中药的制备方法,将上述药材经粉碎、过筛、混合均匀,不加辅料直接灌胶囊或按常规方法制备丸剂,或是加入适当辅料、并加入粘合剂制粒,干燥后灌装胶囊或加适量润滑剂后压成片剂。
本发明的治疗肺癌中药的制备方法,将上述药材加其重量8-12倍的水煎煮2-3次或加6-10倍量的质量浓度为50-70%的乙醇提取2-3次,合并煎液或提取液,浓缩至稠膏,按常规方法制备成丸剂,或加适当辅料或不加辅料混合均匀,制粒、干燥、灌装胶囊或加适量润滑剂后压制成片剂。
服用方法:每次服用折合成药材量为5 ~ 10g,每日三次。三个月为1疗程。
下面为本发明中各药材的功能及作用:
西洋参:甘、微苦,凉。归心、肺、肾经。功能主治:补气养阴,清热生津。用于气虚阴亏,内热,咳喘痰血,虚热烦倦,消渴,口燥咽干。西洋参有抗疲劳、抗氧化、抗应激、抑制血小板聚集、降低血液凝固性的作用,另外,对糖尿病患者还有调节血糖的作用。
黄芪:性味:甘,微温。归经:归肺、脾、肝、肾经。功效主治:黄芪有益气固表、敛汗固脱、托疮生肌、利水消肿之功效。用于治疗气虚乏力,中气下陷,久泻脱肛,便血崩漏,表虚自汗,痈疽难溃,久溃不敛,血虚萎黄,内热消渴,慢性肾炎,蛋白尿,糖尿病等。炙黄芪益气补中,生用固表托疮。
浮海石:咸,寒。清肺火;化老痰;利水通淋;软坚散结。痰热壅肺;咳喘痰稠难咯;小便淋沥涩痛;瘿瘤瘰疬。
生地:清热、生津、润燥、滑肠、破瘀、生新、止痛、调经、金疮瘀、凉血、止血。多用于治疗阴虚内热、骨蒸劳热、舌绛烦渴、发斑发疹等问题。
熟地:甘,微温。归肝、肾经。功效:补血养阴,填精益髓。熟地味甘、性平而入血分,功能滋阴补血、补精益髓。治阴虚血少,脑髓空虚所至的腰膝痿弱、劳嗽骨蒸,遗精,崩漏,月经不调,消渴,溲数,耳聋、目昏,心悸失眠、健忘,盗汗等。
生地与熟地二者合用,取其既能补益,又能清热之功用。用于治疗阴血亏虚、兼有热象的病症。
百部:甘、苦,微温。归肺经。功能主治:润肺止咳;杀虫灭虱。主新久咳嗽;肺痨;百日咳;蛲虫病;体虱;癣疥。
栝楼:性味:甘苦,寒。归经:入肺、胃、大肠经。功能主治:润肺,化痰,散结,润肠。治痰热咳嗽,胸痹,结胸,肺痿咳血,消渴,黄疸,便秘,痈肿初起。
杏仁:性味:苦,微温;有小毒。功效:止咳平喘,润肠通便。用于咳嗽气喘。润肠通便,具有镇痛作用,因此国内有人用苦杏仁治疗晚期肝癌可解除病人的痛苦,有的甚至不需服用止痛药,抗肿瘤作用,能够选择性杀死癌细胞,而对正常细胞几乎无害。
玄参:味甘、苦、咸; 性微寒。归肺,胃,肾经。功效:清热凉血,泻火解毒,滋阴。
主治:温邪入营,内陷心包,温毒发斑,热病伤阴、舌绛烦渴、津伤便秘、骨蒸劳嗽、目赤、咽痛、瘰疬、白喉、痈肿疮毒。
山慈菇:性味归经:甘、微辛,凉。归肝、脾经。功能主治:清热解毒,化痰散结。用于痈肿疔毒,瘰疬痰核,淋巴结结核,蛇虫咬伤。
胆星:味苦,性凉。入心、肝、肺三经。清火化痰,镇惊定痼。治中风痰迷,惊风癫痫,痰火喘嗽,头风眩晕。
薏苡仁:性凉,味甘、淡。健脾渗湿,除痹止泻。薏米可用于治疗水肿、脚气、小便不利、湿痹拘挛、脾虚泄泻。
五味子:性味归经:温;酸、甘;归肺、心、肾经。敛肺,滋肾,生津,收汗,涩精。治肺虚喘咳,口干作渴,自汗,盗汗,劳伤羸瘦,梦遗滑精,久泻久痢。
百合:百合味甘,性微寒。归心、肺经。功能主治:养阴润肺,清心安神。用于阴虚久咳,痰中带血,虚烦惊悸,失眠多梦,精神恍惚。具有养阴润肺止咳功效,用于肺阴虚的燥热咳嗽,如百花膏。治肺虚久咳,劳嗽咯血,如百合固金汤。具有清心安神功效,用于热病余热未清,虚烦惊悸,失眠多梦等。药用时煎服,10~30g。清心宜生用,润肺蜜炙用。
茯苓:性味:甘、淡,平。归经:归心经、肺经、脾经、肾经。功能:利水药;渗湿利尿药。
白术:性味:味苦;甘;性温。归经:归脾;胃经。功效:健脾益气;健胃,燥湿利尿;化痰,止汗;安胎。
甘草:性味:味甘,性平,无毒。功能主治:治五脏六腑寒热邪气,坚筋骨,长肌肉,倍气力,解毒,久服轻身延年。生用泻火热,熟用散表寒,去咽痛,除邪热,缓正气,养阴血,补脾胃,润肺。
麦门冬:甘、微苦,微寒。归肺、心、胃经。功效: 养阴生津,润肺止咳:用于肺胃阴虚之津少口渴、干咳咯血;心阴不足之心悸易惊及热病后期热伤津液等证。
浙贝母:性味:味大苦,性寒。归经:入手太阴、少阳,足阳明、厥阴。功用主治:清热化痰,散结解毒。治风热咳嗽,肺痈喉痹,瘰疬,疮疡肿毒。
半夏:辛、温。归脾、胃、肺经。半夏辛散温燥有毒,主入脾胃兼入肺,能行水湿,降逆气,而善祛脾胃湿痰。水湿去则脾健而痰涎自消,逆气降则胃和而痞满呕吐自止,故为燥湿化痰,降逆止呕,消痞散结之良药。既主治脾湿痰壅之痰多咳喘气逆,如二陈汤、小青龙汤,又治湿痰上犯之眩晕心悸失眠,如半夏白术天麻汤,还可治风痰吐逆,头痛肢麻,半身不遂,口眼歪斜等症,如玉壶丸。此外,半夏善燥湿降逆止呕,又性温兼散寒,主治胃寒及痰饮呕吐,如小半夏汤。若治疗其他原因所致的呕恶,当据情配伍它药。还有,半夏又善治胃气上逆之恶心呕吐,痰湿中阻之胸脘痞闷,气郁痰结咽中如有物阻之梅核气,如半夏厚朴汤。若痰热互结之心下痞,如小陷胸汤 。还可治痰湿凝滞经络或肌肉所致的瘿瘤痰核及痈疽肿毒,未化脓者,可单用生品为末,醋调外敷。最后,半夏和胃之功,治疗胃不和卧不安,与秫米合用,如半夏秫米汤;取本品行湿润燥之功,治疗老人火衰便秘,与硫黄合用,如半硫丸。
沙参:性味:甘,凉。功能主治:养阴清肺,益胃生津。主治阴虚发热,肺燥干咳,肺痿痨嗽,痰中带血,喉痹咽痛,津伤口渴。沙参具有滋阴生津、清热凉血之功,配合放 化疗用于肿瘤患者,尤其是对晚期肿瘤病人血枯阴亏、肺阴虚之肺癌、消化道肿瘤术后气阴两虚或因放疗而伤阴引起的津枯液燥者,具有较好的疗效。
白花蛇舌草:性味与归经:微苦、微甘,微寒。归心、肝、脾经。功能与主治:清热解毒,消痈散结,利水消肿。用于咽喉肿痛,肺热喘咳,热淋涩痛,湿热黄疸,毒蛇咬伤,疮肿热痈。
当归:性味:味甘;辛;苦;性温。归经:归肝;心;脾经。功效:补血;活血;调经止痛;润燥滑肠。主治:血虚诸证;月经不调;经闭;痛经;症瘕结聚;崩漏;虚寒腹痛;痿痹;肌肤麻木;肠燥便难;赤痢后重;痈疽疮疡;跌扑损伤。
桔梗:性味:味苦;辛;性平。 归经:肺经。功效:宣肺、祛痰、利咽、排脓、利五脏、补气血、补五劳、养气。主治:咳嗽痰多、咽喉肿痛、肺痈吐脓、胸满胁痛、痢疾腹痛、口舌生疮、目赤肿痛、小便癃闭。用于咳嗽痰多,胸闷不畅,咽痛,音哑,肺痈吐脓,疮疡脓成不溃。
红白二丸:性味归经:苦、酸,平。功能主治:活血调经,止血止痢。用于月经不调,赤白带下,痢疾,吐血,衄血,跌打损伤出血。
青琅玕:气味 辛,平,无毒。主治:身痒,火疮痈疡,疥瘙死肌。白秃,浸淫在皮肤中,煮炼服之,起阴气,可化为丹。疗手足逆胪。石阑干:主石淋,破血,产后恶血,磨服,或煮服,亦火烧投酒中服。
苘麻根:苦、涩、寒。功能主治:清暑热、化湿浊、顺气和胃、主治暑热胸闷,口渴,呕吐,不思饮食,口疮口糜。
落霜红:性味与归经:甘、苦,凉。功能与主治:清热解毒,凉血止血。用于烧烫伤,创伤出血,疮疖溃疡,肺痈。
一支箭:药性;苦,甘,微寒,归肝经,用法与用量:消热解毒,活血祛瘀,主治疼肿,毒蛇咬伤,烫伤,跌打等。
本发明的有益效果:药材西洋参、杏仁、山慈菇、薏苡仁、百合、茯苓、白术、半夏、沙参、白花蛇舌草、五味子、甘草为君药,具有抗癌功效,辅以当归 、桔梗镇痛,黄芪益气固表、敛汗固脱、托疮生肌、利水消肿,浮海石清肺火;化老痰;利水通淋;软坚散结,生地清热、生津、润燥、滑肠、破瘀、生新、止痛、金疮瘀、凉血、止血,熟地补血养阴,填精益髓,百部润肺止咳,栝楼润肺,化痰,散结,润肠,玄参清热凉血,泻火解毒,滋阴,胆星清火化痰,镇惊定痼,麦门冬养阴生津,润肺止咳,浙贝母清热化痰,散结解毒。诸药合用,具有益气养阴,化痰散结的功效,对各种肺癌有显著的疗效,尤其对气阴两虚型的肺癌有着更为显著的疗效。同时本药物发明配合手术、放疗、化疗,可以起到减少放疗化疗的毒副作用,可以显著提高放疗化疗的疗效。对于晚期肺癌患者西医无特殊疗法的,应用本药物发明可以明显改善症状,提高生存质量,延长肺癌患者的生存期,治愈率高达85%,因此本发明有着极高的临床应用价值和极大的经济价值。
(四) 具体实施方式
实施例1 :
处方:西洋参100g、黄芪100g、浮海石100g、生地100g、熟地100g、百部100g、栝楼100g、杏仁100g、玄参100g、山慈菇100g、胆星100g、薏苡仁100g、五味子100g、百合100g、茯苓100g、白术100g、甘草100g、麦门冬100g、浙贝母100g、半夏100g、沙参100g、白花蛇舌草100g、当归100g、桔梗100g。
制备工艺:将处方量药材加其重8倍量的水煎煮3次,合并煎液,浓缩至相对密度为1.23 (50℃)的稠膏,然后制粒、干燥、制得900粒胶囊,每粒装0.8g。每日服用3次,每次服用4粒。
实施例2:
处方:西洋参500g、黄芪500g、浮海石500g、生地500g、熟地500g、百部500g、栝楼500g、杏仁500g、玄参500g、山慈菇500g、胆星150g、薏苡仁500g、五味子500g、百合500g、茯苓500g、白术500g、甘草500g、麦门冬500g、浙贝母500g、半夏500g、沙参500g、白花蛇舌草500g、当归500g、桔梗500g。
制备工艺:将上述处方量药材经粉碎、过80目筛、混合均匀,直接灌胶囊,制得7760粒,每粒装0.75g。每日服用3次,每次服用5粒。
实施例3:
处方:西洋参250g、黄芪250g、浮海石250g、生地250g、熟地250g、百部250g、栝楼250g、杏仁250g、玄参250g、山慈菇250g、胆星75g、薏苡仁250g、五味子250g、百合250g、茯苓250g、白术250g、甘草250g、麦门冬250g、浙贝母250g、半夏250g、沙参250g、白花蛇舌草250g、当归250g、桔梗250g。
制备工艺:将处方量药材加其重8倍量的50%乙醇提取3次,合并提取液,回收乙醇,浓缩至相对密度为1.27 (50℃)的稠膏,加入淀粉2000g,混合均匀,制粒、干燥、加入硬脂酸镁600g,压片,制得6160片,每片重0.8g。每日服用3次,每次服用5片。
实施例4:
处方:西洋参250g、黄芪500g、浮海石250g、生地250g、熟地250g、百部250g、栝楼250g、杏仁250g、玄参250g、山慈菇250g、胆星75g、薏苡仁250g、五味子250g、百合250g、茯苓250g、白术250g、甘草250g、麦门冬250g、浙贝母250g、半夏250g、沙参100g、白花蛇舌草250g、当归250g、桔梗250g、红白二丸200g、青琅玕200g、苘麻根200g、落霜红10g、一支箭200g。
制备工艺:将处方量药材红白二丸、青琅玕、苘麻根、落霜红、一支箭粉碎备用,剩余药材加其重12倍量的70%乙醇提取2次,合并提取液,回收乙醇,浓缩至相对密度为1.22 (50℃)的稠膏,加入上述药粉泛法制丸并抛光,制成浓缩丸,制得3990粒,每丸重0.5g。每日服用3次,每次服用5丸。
实施例5:
处方:西洋参10g、黄芪500g、浮海石200g、生地200g、熟地200g、百部150g、栝楼200g、杏仁150g、玄参200g、山慈菇200g、胆星150g、薏苡仁250g、五味子200g、百合200g、茯苓300g、白术300g、甘草300g、麦门冬200g、浙贝母200g、半夏200g、沙参300g、白花蛇舌草200g、当归200g、桔梗200g。
制备工艺:将上述处方量药材经粉碎、过100目筛、混合均匀,直接灌胶囊或按水丸生产工艺制成为13340粒的水丸,每丸重0.39g。每日服用3次,每次服用15粒。
实施例6:
处方:西洋参250g、黄芪100g、浮海石100g、生地100g、熟地100g、百部75g、栝楼100g、杏仁75g、玄参100g、山慈菇100g、胆星75g、薏苡仁250g、五味子100g、百合100g、茯苓150g、白术150g、甘草150g、麦门冬100g、浙贝母100g、半夏100g、沙参150g、白花蛇舌草100g、当归100g、桔梗100g。
制备工艺:将上述处方量药材,加入过60目筛后加入其重8倍量的水,分两次煎煮,第一次2h,第二次1h,合并煎液,趁热滤过,上清液浓缩至含生药量为1g/ml的浓缩液,浓缩液降温至室温后,在浓缩液中加入重量6-10倍的质量浓度60%的乙醇,密闭冷藏12h,过滤除去杂质,滤液回收乙醇,得到精制液,往精制液中加纯化水至每1ml口服液相当于原生药1g,搅拌均匀,过滤,灌封,灭菌,即制备成口服液(每瓶口服液体积为5-10ml)。每日服用3次,每次服用1瓶。
实施例7:
处方:西洋参100g、黄芪250g、浮海石500g、生地250g、熟地250g、百部250g、栝楼500g、杏仁250g、玄参250g、山慈菇250g、胆星75g、薏苡仁250g、五味子250g、百合250g、茯苓100g、白术250g、甘草250g、麦门冬250g、浙贝母250g、半夏250g、沙参100g、白花蛇舌草250g、当归250g、桔梗200g、红白二丸10g、青琅玕10g、苘麻根10g、落霜红200g、一支箭10g。
制备工艺:将上述处方量药材,过40目筛,制成散剂或袋泡剂,每日服用3次,每次服用5-10g。
实施例8:
处方:西洋参250g、黄芪500g、浮海石250g、生地250g、熟地250g、百部250g、栝楼250g、杏仁250g、玄参250g、山慈菇250g、胆星75g、薏苡仁250g、五味子250g、百合250g、茯苓250g、白术250g、甘草250g、麦门冬250g、浙贝母250g、半夏250g、沙参100g、白花蛇舌草250g、当归250g、桔梗250g、红白二丸100g、青琅玕100g、苘麻根100g、落霜红100g、一支箭100g。
制备工艺:将上述处方量药材,过40目筛后加入其重总重8倍的水,分两次煎煮,第一次2小时,第二次1小时,合并煎液,趁热滤过,所得上清液浓缩至相对密度为1.30(50℃)的稠膏,按稠膏中加入乳糖2800g,混合均匀,制成颗粒,在60℃条件下干燥,整粒,包装,制得630包,每包净重7.4g,每日服用3次,每次服用1包。
实施例9:
处方:西洋参25g、黄芪10g、浮海石10g、生地10g、熟地10g、百部7.5g、栝楼10g、杏仁7.5g、玄参10g、山慈菇10g、胆星7.5g、薏苡仁25g、五味子10g、百合10g、茯苓15g、白术15g、甘草15g、麦门冬10g、浙贝母10g、半夏10g、沙参15g、白花蛇舌草10g、当归10g、桔梗10g。
制备工艺:将上述处方量药材,过80目筛后加入其重总重8倍的水,分两次煎煮,第一次2小时,第二次2小时,合并煎液,服用。
实施例10:临床观察
(1)一般资料
本发明人于2000年至今对500例肺癌患者进行临床观察治疗,年龄28到85岁不等,病程1年-3年不等。
(2)治疗方法:一日三次服用本发明中药,其折合每日服用药材量为5-10g。
(3)临床症状:
a.刺激性咳嗽、乾咳或白色泡沫痰、痰中带血点或血丝;
b.胸闷、哮喘、气促;
c.局限性哮呜音,局限性肺气肿或肺不张的体征;
d.X线胸部平片:见肺内有密度均匀,边缘不整或分叶肿块、或肺内有圆形或椭圆形边缘有切迹或毛刺阴影,有时可见到局部肺气肿、肺不张等;
e.痰细胞学检查找到癌细胞;
f.支气管镜检查窥见癌源病变。
(4)疗效评定标准
治愈:症状体征完全消失;
有效:症状体征较前减轻;
无效:症状体征与治疗前无改善。
(5)治疗效果:
| 患者(年龄) | 病例数 | 治愈数 | 治愈率 | 有效数 | 无效数 | 总有效率 |
| 28-40 | 50 | 42 | 84.5% | 3 | 5 | 90% |
| 41-50 | 85 | 73 | 86.1% | 6 | 6 | 92.9% |
| 51-60 | 173 | 148 | 85.3% | 8 | 17 | 90.1% |
| 61-70 | 105 | 88 | 84.1% | 8 | 9 | 91.4% |
| 71-85 | 87 | 74 | 85% | 6 | 7 | 91.9% |
| 305 | 425 | 85% | 31 | 37 | 91.2% |
临床治愈425例,占85%;有效31例,无效45例,总有效率91.2%。
(6)典型病例:
王某,女,现年58 岁,潍坊潍城区人,于2001 年在潍坊人民医院检查诊断为肺癌,中晚期,当时医院给予的治疗意见是回家静养,经人介绍开始服用本发明的中药治疗三个疗程后停药,痊愈。
赵某,男,现年30岁,菏泽东明县人,与2008年在菏泽市立医院诊断为肺癌中期,当时在医院给予化疗治疗,效果不佳,之后开始服用本发明的中药,两个疗程后治愈,继续服用两个疗程,至今未复发。
张某,女,现年48岁,菏泽东明县人,与2005年,在菏泽市立医院诊断为肺癌晚期,之后服用本发明的中药冲剂治疗,四个疗程后逐渐停药,现可从事农活,痊愈至今未复发。
孙某,女,现年60岁,滨州邹平人,于2010年出现胸闷、哮喘症状,在潍坊人民医院检查诊断为肺癌中期,在医院治疗效果不明显,随后经人介绍服用本发明的中药治疗,经治疗两个疗程后,胸闷、哮喘消失,继续服用3个疗程巩固随停药,现已痊愈至今未复发。
孙某,男,现年78岁,菏泽人,于2009 年出现相应肺组织肺不张的体征在菏泽市中医院诊断为肺癌后期,医院放弃治疗,随后经人介绍服用本发明的中药,经治疗两个疗程后症状消失随停药,且至今未复发。
Claims (8)
1.一种治疗肺癌的中药,其特征在于:由以下重量份数的药材制成:
西洋参100g、黄芪100g、浮海石100g、生地100g、熟地100g、百部100g、栝楼100g、杏仁100g、玄参100g、山慈菇100g、胆星100g、薏苡仁100g、五味子100g、百合100g、茯苓100g、白术100g、甘草100g、麦门冬100g、浙贝母100g、半夏100g、沙参100g、白花蛇舌草100g、当归100g、桔梗100g。
2.一种治疗肺癌的中药,其特征在于:由以下重量份数的药材制成:
西洋参500g、黄芪500g、浮海石500g、生地500g、熟地500g、百部500g、栝楼500g、杏仁500g、玄参500g、山慈菇500g、胆星150g、薏苡仁500g、五味子500g、百合500g、茯苓500g、白术500g、甘草500g、麦门冬500g、浙贝母500g、半夏500g、沙参500g、白花蛇舌草500g、当归500g、桔梗500g。
3.一种治疗肺癌的中药,其特征在于:由以下重量份数的药材制成:
西洋参250g、黄芪250g、浮海石250g、生地250g、熟地250g、百部250g、栝楼250g、杏仁250g、玄参250g、山慈菇250g、胆星75g、薏苡仁250g、五味子250g、百合250g、茯苓250g、白术250g、甘草250g、麦门冬250g、浙贝母250g、半夏250g、沙参250g、白花蛇舌草250g、当归250g、桔梗250g。
4.一种治疗肺癌的中药,其特征在于:由以下重量份数的药材制成:
西洋参10g、黄芪500g、浮海石200g、生地200g、熟地200g、百部150g、栝楼200g、杏仁150g、玄参200g、山慈菇200g、胆星150g、薏苡仁250g、五味子200g、百合200g、茯苓300g、白术300g、甘草300g、麦门冬200g、浙贝母200g、半夏200g、沙参300g、白花蛇舌草200g、当归200g、桔梗200g。
5.一种治疗肺癌的中药,其特征在于:由以下重量份数的药材制成:
西洋参250g、黄芪100g、浮海石100g、生地100g、熟地100g、百部75g、栝楼100g、杏仁75g、玄参100g、山慈菇100g、胆星75g、薏苡仁250g、五味子100g、百合100g、茯苓150g、白术150g、甘草150g、麦门冬100g、浙贝母100g、半夏100g、沙参150g、白花蛇舌草100g、当归100g、桔梗100g。
6.一种治疗肺癌的中药,其特征在于:由以下重量份数的药材制成:
西洋参25g、黄芪10g、浮海石10g、生地10g、熟地10g、百部7.5g、栝楼10g、杏仁7.5g、玄参10g、山慈菇10g、胆星7.5g、薏苡仁25g、五味子10g、百合10g、茯苓15g、白术15g、甘草15g、麦门冬10g、浙贝母10g、半夏10g、沙参15g、白花蛇舌草10g、当归10g、桔梗10g。
7.根据权利要求1至6任意一项所述的治疗肺癌中药的制备方法,其特征在于:将上述药材经粉碎、过筛、混合均匀,不加辅料直接灌胶囊或按常规方法制备丸剂;或是加入适当辅料、并加入粘合剂制粒,干燥后灌装胶囊或加适量润滑剂后压成片剂。
8.根据权利要求1至6任意一项所述的治疗肺癌中药的制备方法,其特征在于:将上述药材加其重量8-12倍的水煎煮2-3次或加6-10倍量的质量浓度为50-70%的乙醇提取2-3次,合并煎液或提取液,浓缩至稠膏,按常规方法制备成丸剂,或加适当辅料混合均匀或不加辅料,制粒、干燥、灌装胶囊或加适量润滑剂后压制成片剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310073474.4A CN103127433B (zh) | 2013-03-08 | 2013-03-08 | 一种治疗肺癌的中药及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310073474.4A CN103127433B (zh) | 2013-03-08 | 2013-03-08 | 一种治疗肺癌的中药及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103127433A CN103127433A (zh) | 2013-06-05 |
| CN103127433B true CN103127433B (zh) | 2014-09-24 |
Family
ID=48488303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310073474.4A Expired - Fee Related CN103127433B (zh) | 2013-03-08 | 2013-03-08 | 一种治疗肺癌的中药及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103127433B (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103535725A (zh) * | 2013-10-21 | 2014-01-29 | 李克峰 | 一种果蔬保健品及其制备方法 |
| CN104352797A (zh) * | 2014-12-04 | 2015-02-18 | 崔合芳 | 一种治疗晚期肺癌的中药及其应用 |
| CN105169270A (zh) * | 2015-10-08 | 2015-12-23 | 郑晨昭 | 一种促进非小细胞肺癌术后恢复的药物、制备方法及使用方法 |
| CN105748929A (zh) * | 2016-03-31 | 2016-07-13 | 广州暨南生物医药研究开发基地有限公司 | 一种含艾叶的治疗肺癌的中药组合物及其制备方法 |
| CN107412547B (zh) * | 2017-08-15 | 2020-08-18 | 中国中医科学院广安门医院 | 一种治疗肺癌的中药组合物及其应用 |
| US10912324B2 (en) * | 2017-10-15 | 2021-02-09 | Heong Jun YU | Food product for improving lymphatic circulation |
| CN109010667A (zh) * | 2018-10-25 | 2018-12-18 | 林洪生 | 一种治疗肺癌的中药组合物及其制备方法 |
| CN109999158A (zh) * | 2018-12-04 | 2019-07-12 | 深圳前海五次元生物科技有限公司 | 一种治疗肺癌的药物组合物及其应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1437977A (zh) * | 2003-01-13 | 2003-08-27 | 许新琳 | 一种专治肺癌的药物 |
| CN1559576A (zh) * | 2004-02-25 | 2005-01-05 | 陈绍先 | 治疗肝癌、肺癌、血癌、胃癌和贲门癌的中草药配方及配制方法 |
| CN101703726A (zh) * | 2009-11-19 | 2010-05-12 | 何玉伟 | 一种治疗肺癌的药物 |
| CN101954022A (zh) * | 2010-10-15 | 2011-01-26 | 林万硕 | 一种用于治疗肺癌的中药组合物 |
-
2013
- 2013-03-08 CN CN201310073474.4A patent/CN103127433B/zh not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1437977A (zh) * | 2003-01-13 | 2003-08-27 | 许新琳 | 一种专治肺癌的药物 |
| CN1559576A (zh) * | 2004-02-25 | 2005-01-05 | 陈绍先 | 治疗肝癌、肺癌、血癌、胃癌和贲门癌的中草药配方及配制方法 |
| CN101703726A (zh) * | 2009-11-19 | 2010-05-12 | 何玉伟 | 一种治疗肺癌的药物 |
| CN101954022A (zh) * | 2010-10-15 | 2011-01-26 | 林万硕 | 一种用于治疗肺癌的中药组合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103127433A (zh) | 2013-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103127433B (zh) | 一种治疗肺癌的中药及其制备方法 | |
| CN101954015B (zh) | 一种治疗肺结核的中药组合物 | |
| CN103550696B (zh) | 一种治疗肺癌的药物 | |
| CN104069474B (zh) | 一种治疗脂溢性脱发的中药组合物及其制备方法 | |
| CN103736072A (zh) | 一种治疗过敏性鼻炎的药物及其制备方法 | |
| CN103751682B (zh) | 一种治疗肺热咳嗽的药物及其制备方法 | |
| CN104043057A (zh) | 一种治疗淋巴癌的中药组合物 | |
| CN104740437A (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
| CN103816440A (zh) | 一种全部以药食同源药材制备的祛痘组合物 | |
| CN101954022B (zh) | 一种用于治疗肺癌的中药组合物 | |
| CN104042981A (zh) | 一种治疗产后便秘的药剂及制备方法 | |
| CN104784476A (zh) | 一种治疗心律不齐的中药胶囊及制备方法 | |
| CN101947303B (zh) | 一种根治高血压的药物及其制备方法 | |
| CN101904984A (zh) | 治疗脱肛病的中草药 | |
| CN106474355A (zh) | 一种治疗心脏病的中药 | |
| CN105079721A (zh) | 一种治疗骨关节炎的中药组合物及其制备方法 | |
| CN104998074A (zh) | 一种治疗胃病的中药及其制备方法 | |
| CN103330861B (zh) | 一种治疗霍乱的药物及其制备方法 | |
| CN104606600A (zh) | 一种治疗间质性肺病的中药组合物及其制备方法 | |
| CN104367928A (zh) | 一种治疗小儿盗汗的药物及其制备方法 | |
| CN103800744A (zh) | 一种全部以药食同源药材制备的祛痘组合物 | |
| CN106798888A (zh) | 一种治疗心肌缺血及心悸怔忡病证的丸剂药物及制备方法 | |
| CN106038994A (zh) | 一种辅助降糖的食药及其制备方法 | |
| CN105250618A (zh) | 一种治疗肝硬化的抗病毒中药组合物及其制备方法 | |
| CN105213946A (zh) | 一种治疗便秘的药物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140924 Termination date: 20210308 |